Skip to main content

Advertisement

SpringerLink
Log in

The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Inadequate vitamin D may be involved in the pathogenesis and or progression of several disorders, including connective tissue diseases. To determine the status of vitamin D in different stages of inflammatory arthritis, the levels of vitamin D in established rheumatoid arthritis (RA) and undifferentiated inflammatory arthritis (UIA) were compared with controls. Patients with RA and UIA entered the study. Serum 25-hydroxyvitamin D (25-OHD) was measured by ELISA method, and concentrations less than 20 ng/ml were considered as deficient levels. In statistical analysis, the Mann–Whitney U test was used for comparing differences between groups and logistic regression analysis with calculation of adjusted odds ratio (OR) was used to determine the association between serum 25-OHD deficiency and disease condition. A total of 108 RA, 39 UIA, and 239 controls were studied. There were no significant differences in mean serum 25-OHD level and frequency of serum 25-OHD deficiency between RA and controls (37 ± 37.7 vs. 33.2 ± 28.6 ng/ml, P = 0.96). But the mean serum 25-OHD level in UIA was significantly lower than in the controls (25.1 ± 23.9 vs. 33.2 ± 28.6 ng ml, P = 0.04). A significant positive association was observed between serum 25-OHD deficiency and UIA (56.4% vs. 35.5%, OR = 2.34, 95% CI, 1.18–4.65, P = 0.021) which remained significant after adjustment for sex and age (adjusted OR = 2.24, 95% CI, 1.01–4.55, P = 0.026). Whereas the association between serum 25-OHD deficiency and RA did not reach statistical significance (40.7% vs. 35.5%, OR = 1.24, 95% CI, 0.78–1.99). These findings indicate higher serum vitamin D deficiency in patients with ongoing arthritis rather than established arthritis. Respecting to deleterious effects of vitamin D deficiency on immune system and progressive nature of UIA, a significant proportion of high risk UIA can be recognized by serum 25-OHD determination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373

    Article  PubMed  CAS  Google Scholar 

  2. Gannagé-Yared MH, Tohmé A, Halaby G (2001) Hypovitaminosis D: a major worldwide public health problem. Presse Med 7(30):653–658

    Google Scholar 

  3. Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endocrinol Metab 95:471–478

    Article  PubMed  Google Scholar 

  4. Cutulo M, Otsa K, Paolino S, Yrrus M, Veldi T, Seriolo B (2008) Vitamin D involvement in rheumatoid arthritis and systemic lupus erythgmatosus. Ann Rheum Dis 67:530–535

    Google Scholar 

  5. Pérez-López FR (2007) Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 58(2):117–137 (Epub 2007 Jun 29)

    Article  PubMed  Google Scholar 

  6. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142

    Article  PubMed  CAS  Google Scholar 

  7. Ranganathan P (2009) Genetics of bone loss in rheumatoid arthritis—role of vitamin D receptor polymorphisms. Rheumatology (Oxford) 48(4):342–346

    Article  CAS  Google Scholar 

  8. Tetlove LC, Wolley DE (1999) The effect of 1 alpha 25-dihydroxyvitamin D3 on matrixmetalloproteinase and prostgalndin E2 production by cells of rheumatoid lesion. Arthritis Res 1:63–70

    Article  Google Scholar 

  9. Albert PJ, Proal AD, Marshall TG (2009) Vitamin D: the alternative hypothesis. Autoimmun Rev 8(8):639–644

    Article  PubMed  CAS  Google Scholar 

  10. Szodoray P, Nakken B, Gaal J et al (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68(3):261–269

    Article  PubMed  CAS  Google Scholar 

  11. Deluca HF, Cantorna MT (2001) Vitamin D: it’s role and uses in immunology. FASEB J 15:2579–2585

    Article  PubMed  CAS  Google Scholar 

  12. Kamen DL, Aranow C (2008) The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 10:273–280

    Article  PubMed  CAS  Google Scholar 

  13. Alele JD, Kamen DL (2010) The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun Rev 9(3):137–139

    Article  PubMed  CAS  Google Scholar 

  14. Cutolo M, Otsa K (2008) Review: vitamin D, immunity and lupus. Lupus 17(1):6–10

    Article  PubMed  CAS  Google Scholar 

  15. Zold E, Szodoray P, Kappelmayer J et al (2008) Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 10:R123

    Article  PubMed  Google Scholar 

  16. Damanhouri LH (2009) Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 30:1291–1295

    PubMed  Google Scholar 

  17. Turhanoğlu AD, Güler H, Yönden Z, Aslan F, Mansuroglu A, Ozer C (2010) The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int. doi:10.1007/s00296-010-1393-6

  18. Craig SM, Yu F, Curtis JR et al (2010) Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. Rheumatol 37(2):275–281

    Article  CAS  Google Scholar 

  19. Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir AM, Balbir-Gurman A (2009) Vitamin D level: is it related to disease activity in inflammatory joint disease? Rheumatol Int. doi:10.1007/s00296-009-1251-6

  20. Patel S, Farrager T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolites levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143–2149

    Article  PubMed  CAS  Google Scholar 

  21. Arnett FC, Edworthy SN, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  22. Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X (2009) Markers of B—lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Res Ther 11:R114

    Article  PubMed  Google Scholar 

  23. Heidari B, Firouzjahi A, Heidari P, Hajian K (2009) The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis. Ann Saudi Med 29(6):467–470

    Article  PubMed  Google Scholar 

  24. Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmune Rev 9:140–143

    Article  CAS  Google Scholar 

  25. Caro-Oleas JL, Fernandez-Suarez A, Reneses CS, Porrino C, Nunez-Roldan A, Wichman SI (2008) Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow—up. Clin Exp Rheumatol 26:461–463

    PubMed  CAS  Google Scholar 

  26. Vaz CC, Couto M, Medeiros D et al (2009) Undifferentiated connective tissue disease: a seven—center cross-sectional a study of 184 patients. Clin Rheumatol 28:915–921

    Article  PubMed  CAS  Google Scholar 

  27. Kudo-Tanaka E, Ohshima S, Ishi M (2007) Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clin Rheumatol 26:1627–1633

    Article  PubMed  Google Scholar 

  28. Emery P, Durez P, Dougados M et al (2010) Impact of T cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis 69:510–516

    Article  PubMed  CAS  Google Scholar 

  29. Jeffery LE, Burke F, Mura M et al (2009) 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and Fox3. J Immunol 183:5458–5467

    Article  PubMed  CAS  Google Scholar 

  30. Cutolo M (2009) Vitamin D and autoimmune rheumatic disease. Rheumatology 48:210–212

    Article  PubMed  CAS  Google Scholar 

  31. Andjelkovic Z, Voojinivic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453–456

    PubMed  CAS  Google Scholar 

  32. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. (2010) Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity an damage. Arthritis Care Res (Hoboken) [Epub ahead of print]. doi:10.1002/acr.20186

  33. Gaal J, Lakos G, Szodoray P et al (2009) Immunological and clinical effects of alphacalcidiol in patients with psoriatic arthropathy: results of an open, follow-up pilot study. Acta Derm Venerol 89:140–144

    PubMed  CAS  Google Scholar 

  34. Gouch A, Sambrook P, Delvin J et al (1998) Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol 25:864–868

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Rheumatology, Rouhani Hospital, Babol University of Medical Science, Babol Iran R, Babol, Iran

    Behzad Heidari

  2. Department of Social Medicine, Babol University of Medical Sciences, Babol, Iran

    Karimollah Hajian-Tilaki

  3. Faculti of Medicine, Tehran Azad University of Medical Sciences, Tehran, Iran

    Parnaz Heidari

Authors
  1. Behzad Heidari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karimollah Hajian-Tilaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Parnaz Heidari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Behzad Heidari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heidari, B., Hajian-Tilaki, K. & Heidari, P. The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls. Rheumatol Int 32, 991–995 (2012). https://doi.org/10.1007/s00296-010-1736-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1736-3

Keywords

Search

Navigation